Enhancing patient-reported outcome measures for drug hypersensitivity: a validated 6-item Quality-of-Life Questionnaire for Patients with Drug Hypersensitivity (DrHy-Q6)

Hugo WF. Mak,Valerie Chiang, Sophia WM. So,Jane CY. Wong, Dorothy LY. Lam, Elaine Lee,Jackie SH. Yim, Antonio Romano,Philip H. Li

The Journal of Allergy and Clinical Immunology: In Practice(2024)

引用 0|浏览5
暂无评分
摘要
BACKGROUND Drug hypersensitivity reactions (DHR) can significantly impair patients’ health-related quality of life (HRQoL). However, tools for HRQoL assessment for patients with DHR are time-consuming and remain underutilized. OBJECTIVE To develop and validate an optimized version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q) designed for everyday clinical use. METHODS Item response theory (IRT), a statistical framework for psychometric measurement, was used to evaluate the 15 questions from the original DrHy-Q for their respective item difficulty, discrimination, and information using prospective data from 243 patients with histories of suspected/confirmed DHR before allergy workup. Accordingly, the best-performing items were identified to develop a 6-item optimized version (DrHy-Q6), which was subsequently validated with another prospective cohort of 156 patients. RESULTS All 15 items of the original DrHy-Q demonstrated satisfactory parameters in IRT analysis, including very high discrimination (>1.7), appropriate difficulty (in between -1.5 and 1.5) and good information (a high and broad peak in the information curve). Six items with top-ranked IRT parameters were identified to construct an optimized version, which we named the DrHy-Q6. The DrHy-Q6 demonstrated a 1-factor structure with an improved fit compared to the original DrHy-Q (comparative fit index = 0.985, Tucker–Lewis’s index = 0.974), excellent convergent validity (Unadjusted Pearson correlation with the full version = 0.955; adjusted = 0.894, p<0.001), reliability (Cronbach’s α and McDonald’s ω = 0.93), divergent validity (Pearson correlation with all Short Form 12-item Healthy Survey Version 2 [SF-12v2] subscales < 0.60, p<0.001) and discriminant validity (significantly higher scores with multiple DHR labels [42.45 ± 27.26 vs. 32.93 ± 26.66], p=0.013). CONCLUSIONS From an IRT perspective, the DrHy-Q and all its constituent items are psychometrically valid for HRQoL assessment. We propose an optimized 6-item version (DrHy-Q6) as an abbreviated alternative for assessing HRQoL in patients with DHR, especially for routine use in clinical practice. Patients and physicians may benefit from its streamlined length and simpler scoring algorithm.
更多
查看译文
关键词
Drug hypersensitivity,Item response theory,Patient-reported outcome measure,Quality of life
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要